The future of obesity treatment lies in combining powerful drug therapies with clinician-led lifestyle interventions.

In this episode, Rob MacNaughton, CEO of Calibrate, discusses the company’s pioneering approach to weight management. He shares how Calibrate blends anti-obesity medications with clinician-led lifestyle interventions to ensure sustainable weight loss outcomes. This model not only helps individuals maintain weight loss but also drives better healthcare outcomes while reducing costs. Rob highlights Calibrate’s commitment to clinical integrity and ongoing research into tapering medication and long-term success, providing valuable insights into the future of obesity treatment.

Tune in and learn how combining medication with lifestyle changes is transforming obesity treatment and delivering lasting health benefits.

Resources:

Connect with and follow Rob MacNaughton on LinkedIn.

Follow Calibrate on LinkedIn and explore their website.